PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
OrthoSpineNews
SEPTEMBER 13, 2024
13, 2024 (GLOBE NEWSWIRE) — PRISM MarketView presents an exclusive Q&A with Brent Ness, CEO and Director of Aclarion, Inc. NEW YORK, Sept. Nasdaq: ACON).
Let's personalize your content